Saturday, March 22, 2014 12:02:44 PM
The smaller Form 4 for 29,000 shares is quite meaningless in the grand scheme of things, also it will be amended because the note doesn't match the transaction code used, they used "D" for disposed and yet the footnote incorrectly states "Purchased". They sold $160,000 of stock, which is not a lot.
The larger Form 4 however is quite different, they sold 1 million shares each day for the past 3 trading days. Yesterday they accounted for a little under 10% of the total volume. The other two days however that is 20-25% of the total daily volume, so it is quite the impact on trading. We were "bottomed" before these shares were being sold, they pushed under these past 3 days along with other market issues. This would have likely traded sideways and slightly up the past 3 days if there wasnt this amount of pressure on trading. This ate another 9-12% because of this selling.
We are unfortunately at that time of year when taxes are done and so some of this could very well be related to that very fact. Although I cannot see $15 million going out in sales for tax purposes, but I can certainly see the smaller Form 4 for that very reason, Executives are often responsible for their own payroll taxes among many other things. He sold 3 years ago on April 7th for a similar amount of money $133,120. I am pretty certain the "Glenn" transaction relates to his own personal taxes.
The large Form 4 for 3 million shares will leave you scratching for days. I know some will try to view it as a Negative event, but the timing is actually a positive in this case. If someone was trying to take advantage of price they certainly are not going to wait after peaking at new 52 week highs and sell after a nearly 25% correction from those highs. This was likely held until results were publicly released and a little time after to show it has nothing to do with recent "information". There 3 separate entities Identified on that Form 4, you have a Holding and Pharmaceutical company owned and operated by the individual "Modi". It is likely the cash was needed for reasons specific to those businesses and this was the perfect lull between public events to sell to fund those operations. He may have needed the money and decided on one large pull at the same time so he had the needed capital for the year.
We can all guess at what it is all about in that case, but we are not likely to learn that answer any time soon. Nothing nefarious about it all and I wouldn't take it as an indication of future NVAX public information. This guy Modi hasn't sold anything ever, and is likely taking a piece of his ownership to build his own company overseas, we can speculate on either a soon departure or even a request by the board to sell down some of his position of ownership for changes in the future. As of the result of these sales he is no longer a "Beneficial Owner" as disclosed by the Sched 13 filed recording that event.
I wouldnt worry about it and actually relieved to see part of the answer as to what drove the price down these past 3 days. I would expect this to now recover at this point as we saw good volume yesterday a solid indication that buying has moved back in.
THE REAL DTCC DISCUSSION
http://investorshub.advfn.com/boards/board.aspx?board_id=23867
Recent NVAX News
- Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/20/2024 06:42:06 PM
- Shah Capital Withdraws Proxy Campaign Against Re-Election of Directors at Novavax’s 2024 Annual Meeting • GlobeNewswire Inc. • 05/20/2024 10:35:00 AM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 05/20/2024 10:09:08 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 01:15:54 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/14/2024 09:02:00 PM
- Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/13/2024 08:10:01 PM
- Novavax to Participate in BofA Securities 2024 Health Care Conference • PR Newswire (US) • 05/13/2024 08:02:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 06:39:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/10/2024 12:07:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 12:05:26 PM
- Novavax Surges 57% Post $1.4 Billion Sanofi Deal; Apple Boosts Data Centers with AI and Internal Chips, and More News • IH Market News • 05/10/2024 12:02:56 PM
- Novavax Reports First Quarter 2024 Financial Results and Operational Highlights • PR Newswire (US) • 05/10/2024 06:15:00 AM
- Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination Vaccines • PR Newswire (US) • 05/10/2024 06:00:00 AM
- Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/08/2024 08:53:29 PM
- Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/07/2024 09:21:35 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 05/07/2024 06:43:55 PM
- Novavax to Host Conference Call to Discuss First Quarter 2024 Financial Results and Operational Highlights on May 10, 2024 • PR Newswire (US) • 05/07/2024 01:25:00 PM
- Tesla’s April Sales Down 18% in China, Amazon’s Multi-Billion Dollar Cloud Expansion in Singapore, and More News • IH Market News • 05/07/2024 11:44:00 AM
- Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/06/2024 08:43:09 PM
- Shah Capital Launches Campaign Urging Stockholders to Vote AGAINST the Re-Election of All of Novavax’s Directors Up for Election at its 2024 Annual Meeting • GlobeNewswire Inc. • 05/06/2024 10:22:33 AM
- Shah Capital nominates two highly qualified independent director candidates for Novavax • GlobeNewswire Inc. • 04/15/2024 10:00:00 AM
- Novavax Presents Data on Updated COVID-19 Vaccine and Progress to Date on its COVID-19-Influenza Combination Vaccine Candidate at World Vaccine Congress 2024 • PR Newswire (US) • 04/01/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:30:14 AM
- Novavax to Participate in TD Cowen's 44th Annual Health Care Conference • PR Newswire (US) • 02/29/2024 09:02:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 01:07:50 PM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM